ATE264102T1 - Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption - Google Patents
Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorptionInfo
- Publication number
- ATE264102T1 ATE264102T1 AT99972537T AT99972537T ATE264102T1 AT E264102 T1 ATE264102 T1 AT E264102T1 AT 99972537 T AT99972537 T AT 99972537T AT 99972537 T AT99972537 T AT 99972537T AT E264102 T1 ATE264102 T1 AT E264102T1
- Authority
- AT
- Austria
- Prior art keywords
- formulations
- nicotine
- pharmaceutical compositions
- compositions containing
- containing nicotine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803986A SE9803986D0 (sv) | 1998-11-23 | 1998-11-23 | New compositions |
PCT/SE1999/001983 WO2000030641A1 (en) | 1998-11-23 | 1999-11-04 | Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE264102T1 true ATE264102T1 (de) | 2004-04-15 |
Family
ID=20413363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99972537T ATE264102T1 (de) | 1998-11-23 | 1999-11-04 | Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption |
Country Status (12)
Country | Link |
---|---|
US (1) | US6676959B1 (de) |
EP (1) | EP1131071B1 (de) |
JP (1) | JP2002530335A (de) |
AT (1) | ATE264102T1 (de) |
AU (1) | AU1434000A (de) |
DE (1) | DE69916486T2 (de) |
DK (1) | DK1131071T3 (de) |
ES (1) | ES2220149T3 (de) |
HK (1) | HK1040614B (de) |
PT (1) | PT1131071E (de) |
SE (1) | SE9803986D0 (de) |
WO (1) | WO2000030641A1 (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
SE0103210D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
US20030087937A1 (en) * | 2001-10-15 | 2003-05-08 | Nils-Olof Lindberg | Nicotine and cocoa powder compositions |
SE0202365D0 (sv) * | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
DE10251963A1 (de) * | 2002-11-08 | 2004-05-19 | Lts Lohmann Therapie-Systeme Ag | Transmucosale pharmazeutische Darreichungsform |
US9358296B2 (en) * | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
SE0300831D0 (sv) * | 2003-03-26 | 2003-03-26 | Pharmacia Ab | New formulations and use therof |
SE0300830D0 (sv) * | 2003-03-26 | 2003-03-26 | Pharmacia Ab | New formulations and use thereof |
US8627828B2 (en) * | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
CN102669810B (zh) | 2003-11-07 | 2014-11-05 | 美国无烟烟草有限责任公司 | 烟草组合物 |
FR2882656B1 (fr) * | 2005-03-07 | 2007-06-22 | Schwartz Laboratoires Robert S | Composition antitabagique |
US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
US7946296B2 (en) * | 2006-05-26 | 2011-05-24 | Philip Morris Usa Inc. | Dissolvable tobacco film strips and method of making the same |
PL2061889T3 (pl) * | 2006-09-13 | 2014-11-28 | 22Nd Century Ltd Llc | Zwiększanie poziomów alkaloidów nikotynowych |
AU2007328373A1 (en) * | 2006-12-01 | 2008-06-12 | Cima Labs Inc. | Oral transmucosal nicotine dosage form |
WO2008091592A1 (en) | 2007-01-22 | 2008-07-31 | Targacept, Inc. | Intranasal, buccal, and sublingual administration of metanicotine analogs |
AU2008215771A1 (en) * | 2007-02-15 | 2008-08-21 | Derma-Young Ltd. | Compositions and methods for enhancing transmucosal delivery |
US8356606B2 (en) * | 2007-06-01 | 2013-01-22 | Philip Morris Usa Inc. | Production of micronized encapsulated tobacco particles for tobacco flavor delivery from an oral pouch |
US9167835B2 (en) | 2008-12-30 | 2015-10-27 | Philip Morris Usa Inc. | Dissolvable films impregnated with encapsulated tobacco, tea, coffee, botanicals, and flavors for oral products |
US9167847B2 (en) | 2009-03-16 | 2015-10-27 | Philip Morris Usa Inc. | Production of coated tobacco particles suitable for usage in a smokeless tobacoo product |
RU2587570C2 (ru) | 2010-04-14 | 2016-06-20 | Алтрия Клаинт Сервисиз Инк. | Отформованный бездымный табачный продукт |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US9763928B2 (en) * | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US9044035B2 (en) | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
US10799548B2 (en) * | 2013-03-15 | 2020-10-13 | Altria Client Services Llc | Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
US11503853B2 (en) | 2013-09-09 | 2022-11-22 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US9375033B2 (en) | 2014-02-14 | 2016-06-28 | R.J. Reynolds Tobacco Company | Tobacco-containing gel composition |
EP3871515A1 (de) | 2014-05-27 | 2021-09-01 | R. J. Reynolds Tobacco Company | Nikotinsalze, co-kristalle und salz-co-kristallkomplexe |
US10881133B2 (en) | 2015-04-16 | 2021-01-05 | R.J. Reynolds Tobacco Company | Tobacco-derived cellulosic sugar |
US10869497B2 (en) | 2015-09-08 | 2020-12-22 | R.J. Reynolds Tobacco Company | High-pressure cold pasteurization of tobacco material |
DK3379952T3 (da) | 2015-11-25 | 2024-01-08 | Reynolds Tobacco Co R | Nikotinsalte, co-krystaller og salt-co-krystalkomplekser |
US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
US10499684B2 (en) | 2016-01-28 | 2019-12-10 | R.J. Reynolds Tobacco Company | Tobacco-derived flavorants |
US11154087B2 (en) | 2016-02-02 | 2021-10-26 | R.J. Reynolds Tobacco Company | Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds |
US11091446B2 (en) | 2017-03-24 | 2021-08-17 | R.J. Reynolds Tobacco Company | Methods of selectively forming substituted pyrazines |
WO2019049049A1 (en) | 2017-09-05 | 2019-03-14 | R. J. Reynolds Tobacco Company | SALTS, CO-CRYSTALS, AND CO-CRYSTAL COMPLEXES OF NICOTINE SALTS |
US20190307082A1 (en) | 2018-04-05 | 2019-10-10 | R.J. Reynolds Tobacco Company | Oriental tobacco production methods |
WO2019239356A1 (en) | 2018-06-15 | 2019-12-19 | R. J. Reynolds Tobacco Company | Purification of nicotine |
WO2021116855A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
WO2021116865A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Agents for oral composition |
CA3211601A1 (en) | 2021-03-09 | 2022-09-15 | Jr. Darrell Eugene Holton | Oral products and methods of manufacture |
US20220354785A1 (en) | 2021-04-22 | 2022-11-10 | Nicoventures Trading Limited | Oral lozenge products |
WO2022234522A1 (en) | 2021-05-06 | 2022-11-10 | Nicoventures Trading Limited | Oral compositions and related methods for reducing throat irritation |
WO2023053062A1 (en) | 2021-09-30 | 2023-04-06 | Nicoventures Trading Limited | Oral product with a basic amine and an ion pairing agent |
CA3238147A1 (en) | 2021-11-15 | 2023-05-19 | Christopher Keller | Products with enhanced sensory characteristics |
WO2023248187A1 (en) | 2022-06-24 | 2023-12-28 | Nicoventures Trading Limited | Oral composition comprising a receptor modulator |
GB202214775D0 (en) | 2022-10-07 | 2022-11-23 | Nicoventures Trading Ltd | Oral product |
WO2024074842A1 (en) | 2022-10-07 | 2024-04-11 | Nicoventures Trading Limited | Oral product |
GB202214803D0 (en) | 2022-10-07 | 2022-11-23 | Nicoventures Trading Ltd | Oral product |
WO2024074843A1 (en) | 2022-10-07 | 2024-04-11 | Nicoventures Trading Limited | Oral product |
GB202214771D0 (en) | 2022-10-07 | 2022-11-23 | Nicoventures Trading Ltd | Oral product |
WO2024074839A1 (en) | 2022-10-07 | 2024-04-11 | Nicoventures Trading Limited | Oral product |
WO2024095163A1 (en) | 2022-11-01 | 2024-05-10 | Nicoventures Trading Limited | Oral composition comprising encapsulated ph adjusting agent |
GB202216465D0 (en) | 2022-11-04 | 2022-12-21 | Nicoventures Trading Ltd | Oral product |
WO2024095011A1 (en) | 2022-11-04 | 2024-05-10 | Nicoventures Trading Limited | Oral product |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783207A (en) | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
JPS62175141A (ja) * | 1986-01-29 | 1987-07-31 | Kazuo Takatsu | 複合チヨコレ−ト |
US5017400A (en) * | 1988-06-10 | 1991-05-21 | Suomen Xyrofin Oy | Non-cariogenic sweetener |
US5004601A (en) * | 1988-10-14 | 1991-04-02 | Zetachron, Inc. | Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
US5098730A (en) * | 1988-11-14 | 1992-03-24 | Cultor Ltd. | Dietetic sweetening composition |
US5512306A (en) | 1992-06-19 | 1996-04-30 | Pharmica Ab | Smoking substitute |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
JPH0940564A (ja) * | 1995-07-26 | 1997-02-10 | Taiyo Kagaku Co Ltd | 悪酔予防改善用組成物 |
JPH0956333A (ja) * | 1995-08-21 | 1997-03-04 | Kozaburo Shiba | 機能性梅チョコレート |
DE69811378T2 (de) * | 1997-10-03 | 2004-02-12 | Cary Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) | Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion |
-
1998
- 1998-11-23 SE SE9803986A patent/SE9803986D0/xx unknown
-
1999
- 1999-11-04 EP EP99972537A patent/EP1131071B1/de not_active Expired - Lifetime
- 1999-11-04 AT AT99972537T patent/ATE264102T1/de not_active IP Right Cessation
- 1999-11-04 PT PT99972537T patent/PT1131071E/pt unknown
- 1999-11-04 US US09/856,522 patent/US6676959B1/en not_active Expired - Fee Related
- 1999-11-04 JP JP2000583524A patent/JP2002530335A/ja active Pending
- 1999-11-04 ES ES99972537T patent/ES2220149T3/es not_active Expired - Lifetime
- 1999-11-04 DK DK99972537T patent/DK1131071T3/da active
- 1999-11-04 WO PCT/SE1999/001983 patent/WO2000030641A1/en active IP Right Grant
- 1999-11-04 AU AU14340/00A patent/AU1434000A/en not_active Abandoned
- 1999-11-04 DE DE69916486T patent/DE69916486T2/de not_active Expired - Lifetime
-
2002
- 2002-02-18 HK HK02101182.4A patent/HK1040614B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1131071A1 (de) | 2001-09-12 |
DK1131071T3 (da) | 2004-05-10 |
HK1040614B (zh) | 2004-10-08 |
AU1434000A (en) | 2000-06-13 |
DE69916486T2 (de) | 2004-08-26 |
DE69916486D1 (de) | 2004-05-19 |
SE9803986D0 (sv) | 1998-11-23 |
ES2220149T3 (es) | 2004-12-01 |
WO2000030641A1 (en) | 2000-06-02 |
JP2002530335A (ja) | 2002-09-17 |
HK1040614A1 (en) | 2002-06-21 |
PT1131071E (pt) | 2004-06-30 |
US6676959B1 (en) | 2004-01-13 |
EP1131071B1 (de) | 2004-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE264102T1 (de) | Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption | |
EE200300033A (et) | Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
EP1708685A4 (de) | Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von opiaten | |
IS8726A (is) | Meðferðarfræðilegar samsetningar þrýstingslækkandi efna og efna sem hamla gegn æðamyndun | |
MXPA06000381A (es) | Composicion de dulce dental antiplaca y que puede ser masticada. | |
EE05149B1 (et) | Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
DE60233967D1 (de) | Verbesserte essbare filmformulierungen mit maltodextrin | |
YU60900A (sh) | Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
UA37278C2 (uk) | Протикашльова фармацевтична композиція для перорального введення | |
DK1052973T3 (da) | Transmucosale formuleringer af levosimendan | |
IL140588A0 (en) | Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents | |
IS6919A (is) | Stöðug lyfjablanda sem felur í sér torsemíð afbrigði II | |
BR0313224A (pt) | Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicos | |
DE60016567D1 (de) | Makrophagenhaltige zusammensetzung mit antiinfektiösen und hematopoietischen eigenschaften sowie deren herstellungsmethode | |
SE0103210D0 (sv) | New formulations and use thereof | |
DE69815277T2 (de) | Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung | |
RU98101617A (ru) | Средство для лечения заболеваний пародонта и травматических повреждений слизистой оболочки полости рта "виспосил" | |
DE69938347D1 (de) | Medikamentöse verabreichung von nikotin in form von kaugummi | |
DE50311479D1 (de) | Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1131071 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |